Zoetis (ZTS) Current Taxes (2012 - 2026)
Zoetis' (ZTS) quarterly Current Taxes came in at $211.0 million in Q1 2026, little changed year-on-year from $211.0 million in Q1 2025, and up 45.52% on a QoQ basis from $145.0 million in Q4 2025.
Zoetis (ZTS) Current Taxes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Current Taxes data on file, last reported at $211.0 million in Q1 2026.
- On a quarterly basis, Current Taxes changed 0.0% year-over-year to $211.0 million in Q1 2026; TTM through Mar 2026 was $211.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $145.0 million, up 55.91% from the prior year.
- Current Taxes for Q1 2026 stood at $211.0 million, up from $145.0 million in the prior quarter.
- Over the last five years, Current Taxes for ZTS reached as high as $277.0 million in Q1 2023 and fell as low as $68.0 million in Q2 2022.
- Historically, Current Taxes has averaged $140.2 million across 5 years, with a median of $142.0 million in 2022.
- Across the five-year window, Current Taxes soared 313.16% in 2022 and plunged 32.64% in 2024, its largest moves.
- Year by year, Current Taxes stood at $157.0 million in 2022, then retreated by 29.94% to $110.0 million in 2023, then dropped by 15.45% to $93.0 million in 2024, then soared by 55.91% to $145.0 million in 2025, then surged by 45.52% to $211.0 million in 2026.
- Per Business Quant data, the three most recent Current Taxes figures were $211.0 million in Q1 2026, $145.0 million in Q4 2025, and $152.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.00 Mn |
| Dec 31, 2025 | 145.00 Mn |
| Sep 30, 2025 | 152.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Dec 31, 2024 | 93.00 Mn |
| Sep 30, 2024 | 97.00 Mn |
| Jun 30, 2024 | 82.00 Mn |
| Mar 31, 2024 | 230.00 Mn |
| Dec 31, 2023 | 110.00 Mn |
| Sep 30, 2023 | 144.00 Mn |
| Jun 30, 2023 | 87.00 Mn |
| Mar 31, 2023 | 277.00 Mn |
| Dec 31, 2022 | 157.00 Mn |
| Sep 30, 2022 | 84.00 Mn |
| Jun 30, 2022 | 68.00 Mn |
| Mar 31, 2022 | 142.00 Mn |
| Dec 31, 2021 | 38.00 Mn |
| Sep 30, 2021 | 91.00 Mn |
| Jun 30, 2021 | 43.00 Mn |